Minimization of Immunosuppression and Tolerance Induction in Reconstructive Transplantation
Tóm tắt
Từ khóa
Tài liệu tham khảo
Gilbert R. Transplant is successful with a cadaver forearm. Med Trib Med News. 1964;5:20–3.
Black KS, Hewitt CW, Fraser LA, et al. Composite tissue (limb) allografts in rats. II. Indefinite survival using low-dose cyclosporine. Transplantation. 1985;39:365–8.
• Schneeberger S, Landin L, Jableki J, et al. Achievements and challenges in composite tissue allotransplantation. Transl Int. 2011;24:760–9.
• Petruzzo P, Dubernard JM. The international registry on hand and composite tissue allotransplantation. Clin Transpl. 2011;24:247–53.
Ravindra KV. Ildstad ST: immunosuppressive protocols and immunological challenges related to hand transplantation. Hand Clin. 2011;27:467–79.
Petruzzo P, Lanzetta M, Dubernard J-M, et al. The international registry on hand and composite tissue transplantation. Transplantation. 2010;90:1590–4.
• Chang J, Davis CL, Mathes DW. The impact of current immunosuppression strategies in renal transplantation on the field of reconstructive transplantation. J Reconstr Microsurg. 2012;28:7–19.
Siemionow MZ, Papay F, Djohan R, et al. First U.S. near-total human face transplantation: a paradigm shift for massive complex injuries. Plast Reconstr Surg. 2010;125:111–22.
Kanitakis J, Badet L, Petruzzo P, et al. Clinicopathologic monitoring of the skin and oral mucosa of the first human face allograft: report on the first eight months. Transplantation. 2006;82:1610–5.
Siemionow M, Ozturk C. Face transplantation: outcomes, concerns, controversies, and future directions. J Craniofac Surg. 2012;23:254–9.
Gorantla V, Maldonado C, Frank J, Barker JH. Composite tissue allotransplantation (CTA): current status and future insights. Eur J Trauma. 2001;27:267–74.
Sugita K, Kabashima K, Atarashi K, et al. Innate immunity mediated by epidermal keratinocytes promotes acquired immunity involving Langerhans cells and T cells in the skin. Clin Exp Immunol. 2007;147:176–83.
Uchi H, Terao H, Koga T, Furue M. Cytokines and chemokines in the epidermis. J Dermatol Sci. 2000;24(Suppl 1):S29–38.
Gorantla VS, Demetris AJ. Acute and chronic rejection in upper extremity transplantation: what have we learned? Hand Clin. 2011;27:481–93. ix.
Lee WP, Yaremchuk MJ, Pan YC, et al. Relative antigenicity of components of a vascularized limb allograft. Plast Reconstr Surg. 1991;87:401–11.
Devauchelle B, Badet L, Lengelé B, et al. First human face allograft: early report. Lancet. 2006;368:203–9.
Granger DK, Briedenbach WC, Pidwell DJ, et al. Lack of donor hyporesponsiveness and donor chimerism after clinical transplantation of the hand. Transplantation. 2002;74:1624–30.
Taieb A, Clavijo-Alvarez JA, Hamad GG, Lee WPA. Immunologic approaches to composite tissue allograft. J Hand Surg. 2007;32:1072–85.
Siemionow M, Nasir S. Impact of donor bone marrow on survival of composite tissue allografts. Ann Plast Surg. 2008;60:455–62.
Foster RD, Fan L, Neipp M, et al. Donor-specific tolerance induction in composite tissue allografts. Am J Surg. 1998;176:418–21.
Prabhune KA, Gorantla VS, Maldonado C, et al. Mixed allogeneic chimerism and tolerance to composite tissue allografts. Microsurgery. 2000;20:441–7.
• Pilat N, Hock K, Wekerle T. Mixed chimerism through donor bone marrow transplantation: a tolerogenic cell therapy for application in organ transplantation. Curr Opin Organ Transpl. 2012;17:63–70.
Lechler RI, Sykes M, Thomson AW, Turka L. Organ transplantation—how much of the promise has been realized? Nat Med. 2005;11:605–13.
Scandling JD, Busque S, Dejbakhsh-Jones S, et al. Tolerance and chimerism after renal and hematopoietic-cell transplantation. New Engl J Med. 2008;358:362–8.
Kawai T, Cosimi AB, Spitzer TR, et al. HLA-mismatched renal transplantation without maintenance immunosuppression. New Engl J Med. 2008;358:353–61.
• Leventhal J, Abecassis M, Miller J, et al. Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation. Sci Transl Med. 2012; 4:124ra28.
Scandling JD, Busque S, Shizuru J, et al. Induced immune tolerance for kidney transplantation. New Engl J Med. 2011;365:1359–60.
Starzl TE, Lakkis FG. The unfinished legacy of liver transplantation: emphasis on immunology. Hepatology. 2006;43:S151–63.
Levitsky J. Operational tolerance: past lessons and future prospects. Liver Transpl. 2011;17:222–32.
Lopez M, Clarkson MR, Albin M, et al. A novel mechanism of action for anti-thymocyte globulin: induction of CD4+ CD25+ Foxp3+ regulatory T cells. J Am Soc Nephrol. 2006;17:2844–53.
Bozulic LD, Breidenbach WC, Ildstad ST. Past, present, and future prospects for inducing donor-specific transplantation tolerance for composite tissue allotransplantation. Semin Plast Surg. 2007;21:213–25.
Brandacher G, Lee WA, Schneeberger S. Minimizing immunosuppression in hand transplantation. Exp Rev Clin Immunol. 2012;8:673–84.
Ezzelarab M, Thomson AW. Tolerogenic dendritic cells and their role in transplantation. Semin Immunol. 2011;23:252–63.
Siemionow M, Klimczak A, Unal S, et al. Hematopoietic stem cell engraftment and seeding permits multi-lymphoid chimerism in vascularized bone marrow transplants. Am J Transpl. 2008;8:1163–76.
Pilat N, Sayegh MH, Wekerle T. Costimulatory pathways in transplantation. Semin Immunol. 2011;23:293–303.
Issa F, Hester J, Goto R, Nadig SN, Goodacre TE, Wood K. Ex vivo-expanded human regulatory T cells prevent the rejection of skin allografts in a humanized mouse model. Transplantation. 2010;90:1321–7.
Larsen CP, Pearson TC, Adams AB, et al. Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive properties. Am J Transpl. 2005;5:443–53.
Siemionow MZ, Izycki DM, Zielinski M. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol. Transplantation. 2003;76:1662–8.
Hautz T, Brandacher G, Engelhardt TO, et al. How reconstructive transplantation is different from organ transplantation—and how it is not. Transpl Proc. 2011;43:3504–11.
Mathes DW, Hwang B, Graves SS, et al. Tolerance to vascularized composite allografts in canine mixed hematopoietic chimeras. Transplantation. 2011;92:1301–8.
Schneeberger S, Wachtman GV, Gorantla VS, et al. Utilization of bone marrow cells for immunomodulation in transplantation. Am J Transpl. 2010;4(Suppl 4):116.
Hettiaratchy S, Melendy E, Randolph MA, et al. Tolerance to composite tissue allografts across a major histocompatibility barrier in miniature swine. Transplantation. 2004;77:514–21.
• Barth RN, Rodriguez ED, Mundinger GS, et al. Vascularized bone marrow-based immunosuppression inhibits rejection of vascularized composite allografts in nonhuman primates. Am J Transpl. 2011;11:1407–16.
• Schneeberger S, Gorantla VS, Brandacher G, et al. Upper-extremity transplantation using a cell-based protocol to minimize immunosuppression. Ann Surg. 2012 (Epub ahead of print).
Starzl TE, Murase N, Abu-Elmagd K, et al. Tolerogenic immunosuppression for organ transplantation. Lancet. 2003;361:1502–10.
Crop M, Baan C, Weimar W, Hoogduijn M. Potential of mesenchymal stem cells as immune therapy in solid-organ transplantation. Transpl Int. 2009;22:365–76.
Klimczak A, Agaoglu G, Carnevale KA, Siemionow M. Applications of bilateral vascularized femoral bone marrow transplantation for chimerism induction across the major histocompatibility (MHC) barrier: part II. Ann Plast Surg. 2009;57:422–30.
Fändrich F. Tolerance in clinical transplantation: progress, challenge or just a dream? Langenbecks Arch Surg. 2011;396:475–87.
• Kuo Y-R, Chen C–C, Shih H-S, et al. Prolongation of composite tissue allotransplant survival by treatment with bone marrow mesenchymal stem cells is correlated with T-cell regulation in a swine hind-limb model. Plast Reconstr Surg. 2011;127:569–79.
Le Blanc K, Rasmusson I, Sundberg B, et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet. 2004;363:1439–41.
Taylor KN, Laszkowska M, Cohick E, Colson YL. Induction of FoxP3 + CD4 + CD25 + regulatory T cells by a bone marrow population distinct from plasmacytoid-DC. Cell Immunol. 2008;251:43–9.